In this context, differently than COVID-19 patients with diabetes who exhibited increased ACE2 and TMPRSS2 receptor expression in PBMCs, the PDM patients investigated herein had no altered expression patterns for these receptors (3). This evidence concerns the gene ACE2 and diabetes mellitus.